Cashew Allergy Prevalence and Sensitization in 1-Year-Old Infants

Tim Brettig1, Victoria X Soriano2, Shyamali C Dharmage3

  • 1Population Allergy Group, Murdoch Children's Research Institute, Parkville, Melbourne, Victoria, Australia; Centre for Food and Allergy Research, Murdoch Children's Research Institute, Parkville, Melbourne, Victoria, Australia.

Insights

Cashew allergy affects 1.49% of Australian infants, with eczema and peanut allergy increasing risk. Early introduction of cashew before 12 months showed no association with allergy development.

Area of Science:

  • Pediatric Allergy and Immunology
  • Epidemiology
  • Clinical Nutrition

Background:

  • Cashew allergy is a prevalent tree nut allergy in Australia, yet population-level data on prevalence and risk factors are scarce.
  • Limited understanding exists regarding the specific risk factors and prevalence of cashew allergy in infants.
  • This study addresses the need for data on cashew allergy in a young population in Australia.

Purpose of the Study:

  • To determine the prevalence of cashew sensitization and allergy in 12-month-old infants.
  • To identify significant risk factors associated with cashew allergy in this age group.

Main Methods:

  • Utilized data from the population-based EarlyNuts cohort in Melbourne, Australia.
  • Infants underwent skin prick testing (SPT) for cashew, with positive SPTs followed by food challenges.
  • Questionnaires collected demographic information and potential allergy risk factors, with weighted analysis for population representation.

Main Results:

  • A cashew allergy prevalence of 1.49% (95% CI, 0.91-2.44) was observed in 1,933 infants.
  • Infants with eczema (aOR=5.75) or peanut allergy (aOR=19.30) in their first year had significantly higher odds of cashew allergy.
  • Cashew introduction before 12 months occurred in 25% of participants, with no identified association between introduction timing and allergy development.

Conclusions:

  • This is the first population-based infant cohort study detailing cashew allergy prevalence and risk factors.
  • Eczema and prior peanut allergy are confirmed risk factors for developing cashew allergy.
  • The low rate of early cashew introduction suggests delayed implementation of infant allergen feeding guidelines.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
27.8K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
891
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
753
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
351
Cross-reactivity00:42

Cross-reactivity

Overview
31.3K